An Analysis of the Effect of Re-resection for Intrahepatic Recurrent Cancer and Extrahepatic Metastases of Primary Hepatocellular Carcinoma

罗祥基,陈汉,吴孟超,姜小清,曲增强,胡雷
DOI: https://doi.org/10.3969/j.issn.1004-0242.2005.03.005
2005-01-01
Abstract:To evaluate the effect of re-resection for intrahepatic recurrent cancer and extrahepatic metastases of primary hepatocellular carcinoma.The clinical data of 267 patients with recurrent liver cancer after re-resection were retrospectively analyzed, 205 cases were performed with resection of intrahepatic recurrent cancer, 51 cases with resection of extrahepatic metastases and 11 cases with combined resection of intrahepatic recurrent cancer and extrahepatic metastases.Their clinico-pathologic features and survival were analyzed. In the re-resection of intrahepatic recurrent cancer group,the 1, 3, 5 and 10-year survival rate after second resection was 81.7%, 42.2%, 20.0% and 10.0% respectively, while 78.3%, 30.4%, 13.01% and 8.7% respectively after the third resection.The median survival time was 44 months.In the re-resection of extrahepatic metastases group, the 1, 3, 5 and 10-year survival rate after second resection was 80.4%, 32.0%, 16.0% and 4.3% respectively, while 76.0%, 27.9%, 13.6% and 0 respectively after the third resection. The median survival time was 43 months. The 1, 3, 5 and 10-year survival rate was 100.0%,72.7%,36.4% and 0 respectively in the intrahepatic recurrent and extrahepatic metastases group.The survival was no significantly difference between intrahepatic recurrent and extrahepatic metastases groups (P0.05). [Conclusions] The re-resection can be applicable not only to intrahepatic recurrent cancer but also to extrahepatic metastases in certain selected patients. The re-resection with extrahepatic metastases also prolongs survival.
What problem does this paper attempt to address?